+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Allergic Rhinitis Drugs Market 2019-2023 - Product Image

Global Allergic Rhinitis Drugs Market 2019-2023

  • ID: 4721349
  • Report
  • December 2018
  • Region: Global
  • 113 pages
  • TechNavio
UP TO OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • ALK-Abelló
  • GlaxoSmithKline
  • Merck
  • Sanofi
  • Stallergenes Greer
  • MORE
The rise in R&D of new therapies is expected to drive growth in the market. There has been an increase in the prevalence of allergic diseases globally. If these diseases are not managed at an early stage, allergic diseases such as rhinitis can increase the risk of asthma in patients. Several organizations are trying to understand the pathogenesis of these diseases. The analysts have predicted that the allergic rhinitis drugs market will register a CAGR of close to 4% by 2023.

Market Overview

Increasing prevalence of allergic rhinitis

The increase in the prevalence of allergic rhinitis is expected to increase the pool of patients as well as the consumption of medicine. This worldwide increase in the incidence of allergic rhinitis is likely to drive growth of the allergic rhinitis drugs market.

Competition from generics

The increase in competition from generics is expected to adversely affect the market during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the allergic rhinitis drugs market during the 2019-2023, view this report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Sanofi and Stallergenes Greer, the competitive environment is quite intense. Factors such as the increase in the prevalence of allergic rhinitis and the rise in R&D of new therapies, will provide considerable growth opportunities to allergic rhinitis drugs manufactures. ALK-Abelló, GlaxoSmithKline, Merck, Sanofi, and Stallergenes Greer are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ALK-Abelló
  • GlaxoSmithKline
  • Merck
  • Sanofi
  • Stallergenes Greer
  • MORE

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • Preface
  • Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: PIPELINE ANALYSIS

  • Pipeline analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Antihistamines - Market size and forecast 2018-2023
  • Intranasal corticosteroids - Market size and forecast 2018-2023
  • Immunotherapies - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Market trends

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • ALK-Abelló
  • GlaxoSmithKline
  • Merck
  • Sanofi
  • Stallergenes Greer

PART 15: APPENDIX

  • Research methodology
  • List of abbreviations

List of Exhibits
Exhibit 01: Parent market
Exhibit 02: Global respiratory drugs market
Exhibit 03: Segments of global respiratory drugs market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Pipeline drugs in clinical trials
Exhibit 07: Market definition - Inclusions and exclusions checklist
Exhibit 08: Market size 2018
Exhibit 09: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 10: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 11: Five forces analysis 2018
Exhibit 12: Five forces analysis 2023
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition - Five forces 2018
Exhibit 19: Product - Market share 2018-2023 (%)
Exhibit 20: Comparison by product
Exhibit 21: Antihistamines - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Antihistamines - Year-over-year growth 2019-2023 (%)
Exhibit 23: Intranasal corticosteroids - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Intranasal corticosteroids - Year-over-year growth 2019-2023 (%)
Exhibit 25: Immunotherapies - Market size and forecast 2018-2023 ($ millions)
Exhibit 26: Immunotherapies - Year-over-year growth 2019-2023 (%)
Exhibit 27: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: Others - Year-over-year growth 2019-2023 (%)
Exhibit 29: Market opportunity by product
Exhibit 30: Customer landscape
Exhibit 31: Market share by geography 2018-2023 (%)
Exhibit 32: Geographic comparison
Exhibit 33: Americas - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Americas - Year-over-year growth 2019-2023 (%)
Exhibit 35: EMEA - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: EMEA - Year-over-year growth 2019-2023 (%)
Exhibit 37: APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 38: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 39: Key leading countries
Exhibit 40: Key Leading Countries
Exhibit 41: Market opportunity
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: ALK-Abelló - Vendor overview
Exhibit 49: ALK-Abelló - Business segments
Exhibit 50: ALK-Abelló - Organizational developments
Exhibit 51: ALK-Abelló - Geographic focus
Exhibit 52: ALK-Abelló - Key offerings
Exhibit 53: GlaxoSmithKline - Vendor overview
Exhibit 54: GlaxoSmithKline - Business segments
Exhibit 55: GlaxoSmithKline - Organizational developments
Exhibit 56: GlaxoSmithKline - Geographic focus
Exhibit 57: GlaxoSmithKline - Segment focus
Exhibit 58: GlaxoSmithKline - Key offerings
Exhibit 59: Merck - Vendor overview
Exhibit 60: Merck - Business segments
Exhibit 61: Merck - Organizational developments
Exhibit 62: Merck - Geographic focus
Exhibit 63: Merck - Segment focus
Exhibit 64: Merck - Key offerings
Exhibit 65: Sanofi - Vendor overview
Exhibit 66: Sanofi - Business segments
Exhibit 67: Sanofi - Organizational developments
Exhibit 68: Sanofi - Geographic focus
Exhibit 69: Sanofi - Segment focus
Exhibit 70: Sanofi - Key offerings
Exhibit 71: Stallergenes Greer - Vendor overview
Exhibit 72: Stallergenes Greer - Business segments
Exhibit 73: Stallergenes Greer - Organizational developments
Exhibit 74: Stallergenes Greer - Geographic focus
Exhibit 75: Stallergenes Greer - Key offerings

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • ALK-Abelló
  • GlaxoSmithKline
  • Merck
  • Sanofi
  • Stallergenes Greer
  • MORE
Global Allergic Rhinitis Drugs Market 2019-2023

The analyst recognizes the following companies as the key players in the global allergic rhinitis drugs market: ALK-Abelló, GlaxoSmithKline, Merck, Sanofi, and Stallergenes Greer.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the rise in R&D of new therapies.”

According to the report, one of the major drivers for this market is the increase in the prevalence of allergic rhinitis.

Further, the report states that one of the major factors hindering the growth of this market is the competition from generics.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • ALK-Abelló
  • GlaxoSmithKline
  • Merck
  • Sanofi
  • Stallergenes Greer
Note: Product cover images may vary from those shown
Adroll
adroll